Jacobs Miriam N, Bult Jan M, Cavanagh Kevin, Chesne Christophe, Delrue Nathalie, Fu Jianan, Grange Emma, Langezaal Ingrid, Misztela Dominika, Murray Jenny, Paparella Martin, Stoddart Gilly, Tonn Torsten, Treasure Carol, Tsukano Masaaki, Versteegen Rosemary
UK Health Security Agency, Radiation, Cheimcals and Environmental Hazards, Chilton, OXON, United Kingdom.
PPTA, Brussels, Belgium.
Front Toxicol. 2023 Feb 27;5:1140698. doi: 10.3389/ftox.2023.1140698. eCollection 2023.
The ethical needs and concerns with use and sourcing of human materials, particularly serum, in OECD test guidelines were explored in a dedicated international workshop held in 2019. The health-related aspects of the donation procedure, including tissue screening, donor health, laboratory work health protection, permission from the donor for commercial use, payment of the donors and the potential for exploitation of low-income populations and data protection of the donors; supply, availability, and competition with clinical needs; traceability of the serum and auditability/GLP needs for the Test Guideline Programme, were examined. Here we provide the recommendations of the workshop with respect to the use of human serum, and potentially other human reagents, specifically with regard to test method development for OECD Test Guideline utility as part of the Mutual Acceptance of Data requirement across all OECD member countries. These include informed donor consent terminology, a checklist of human serum information requirements to be included with the Good Laboratory Practise report, and suitable sources for human serum to ensure waste supplies are used, that can no longer be used for medical purposes, ensuring no competition of supply for essential medical use.
2019年举办了一场专门的国际研讨会,探讨了经合组织测试指南中与人类材料(尤其是血清)的使用和来源相关的伦理需求及问题。研究了捐赠程序中与健康相关的方面,包括组织筛查、捐赠者健康、实验室工作中的健康保护、捐赠者对商业用途的许可、对捐赠者的报酬以及剥削低收入人群的可能性和捐赠者的数据保护;供应、可得性以及与临床需求的竞争;血清的可追溯性以及测试指南计划的可审计性/良好实验室规范要求。在此,我们提供该研讨会关于人类血清使用的建议,以及可能的其他人类试剂的建议,特别是关于经合组织测试指南实用性测试方法开发的建议,这是所有经合组织成员国数据互认要求的一部分。这些建议包括知情捐赠者同意术语、良好实验室规范报告应包含的人类血清信息要求清单,以及人类血清的合适来源,以确保使用不再用于医疗目的的废弃供应品,确保基本医疗用途的供应不产生竞争。